AmCad Awarded Frost & Sullivan 2016 New Product Innovation Award for the Thyroid Cancer Detection Solution
Frost & Sullivan analysts independently evaluated two key factors, New Product Attributes (Match to Needs, Reliability, Quality, Positioning, Design) and Customer Impact (Price/Performance Value, Customer Purchase Experience, Customer Ownership Experience, Customer Service Experience, brand equity ). With its strong overall performance, AmCad Biomed Corporation was awarded the 2016 New Production Innovation Award for the Thyroid Cancer Detection solution by leading analyst firm, Frost & Sullivan.